![Mary Reumuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Reumuth
Inga fler pågående positioner
Förmögenhet: - $ per 2026-08-31
Profil
Mary E.
Reumuth worked as an Auditor at Ernst & Young LLP.
Served as Manager-External Financial Reporting at Genzyme Corp.
Worked as Finance Director at Verenium Corp.
from 2007 to 2011.
Held the position of Controller at Enobia Pharma, Inc. from 2011 to 2012.
Was Vice President-Finance & Controller at Kala Bio, Inc. from 2014 to 2017.
Served as Independent Director at Olink Holding AB from 2022 to 2024.
Completed undergraduate education at Texas A&M University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 2025-10-23 | 0 ( -.--% ) | - $ | 2026-08-31 |
Tidigare kända positioner av Mary Reumuth
| Företag | Position | Slut |
|---|---|---|
| KALA BIO, INC. | Finansdirektör/CFO | 2025-11-23 |
| OLIK HLDG | Direktör/Styrelseledamot | 2024-08-01 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Comptroller/Controller/Revisor | 2012-06-01 |
| VERENIUM CORP | Finansdirektör/CFO | 2011-03-01 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Företagsledare/Principal | - |
Mary Reumuths utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
56
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
